Drug Information

Drug General Information
Drug ID
D04VVD
Former ID
DNCL002152
Drug Name
TeloB-Vax
Indication Prostate cancer [ICD9: 185; ICD10:C61] Phase 1 [549237]
Company
Adamis Pharmaceuticals
Target and Pathway
Target(s) Telomerase reverse transcriptase Target Info Modulator [1572591]
NetPath Pathway IL2 Signaling Pathway
Pathway Interaction Database Validated targets of C-MYC transcriptional activation
Regulation of Telomerase
IL2 signaling events mediated by PI3K
Regulation of nuclear beta catenin signaling and target gene transcription
HIF-1-alpha transcription factor network
Reactome Formation of the beta-catenin:TCF transactivating complex
References
Ref 549237Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034068)
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.